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Pine needle oil from crude extract of pine needles has been used as an anti-cancer agent in Traditional
Chinese Medicine. The a-pinene is a natural compound isolated from pine needle oil which has been
shown anti-cancer activity. In previous study, we found that pine needle oil exhibited signiﬁcant
inhibitory effect on hepatoma carcinoma BEL-7402 cells. In this study, we investigate the inhibition of a-
pinene on hepatoma carcinoma BEL-7402 cells in vitro and in vivo and further explore the mechanism.
The results show that liver cancer cell growth was inhibited obviously with inhibitory rate of 79.3%
in vitro and 69.1% in vivo, Chk1 and Chk2 levels were upregulated, CyclinB, CDC25 and CDK1 levels were
downregulated.
© 2015 Japanese Pharmacological Society. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Hepatocellular carcinoma is the third leading cause among
cancer-related death worldwide. It is about 600,000 new cases
annually in the world and more than 90% liver cancer is hepato-
cellular carcinoma (1). Hepatocellular carcinoma is becoming more
and more serious to the mankind. The number of deaths owing to
hepatocellular carcinoma is increasing dramatically around the
world each year and the 5-year survival rate is less than 9% (2). The
clinical treatments for hepatocellular carcinoma aremostly surgical
operation and chemotherapy (3). Therefore, it is necessary to ﬁnd
novel and effective preventive drugs against human hepatoma.
Pine needles, the leaves of the genus pinus in the family pina-
ceae, contain a substance that can suppress free radicals, regulate
and promote body function, improve health, and reinforce immu-
nity (4e6). Pine needle oil from crude extract of pine needles has
been used as an anti-cancer agent in Traditional Chinese Medicine.rtment, Guangdong Pharma-
Mega Center Guangzhou,
ax: þ86 20 39352186.
26.com (L. Ye).
acological Society.
Production and hosting by Elseviea-pinene is a natural compound isolated frompine needle oil which
shows anti-cancer activity. In previous study, we found that pine
needle oil exhibited signiﬁcant inhibitory effect on hepatoma car-
cinoma BEL-7402 cells in vitro and discussed the mechanism pre-
liminarily (7).
In this study, we further assessed the inhibitory effect of a-
pinene on hepatocellular carcinoma BEL-7402 cells in vitro and
in vivo and investigated the molecular mechanism. The results
showed that liver cancer cell growth was inhibited obviously, Chk1
and Chk2 levels were upregulated, CyclinB, CDC25 and CDK1 levels
were downregulated.
2. Materials and methods
2.1. Materials
The a-pinene was isolated from pine needle oil as described
previously (8). The components of pine needle oil were ﬁrst
analyzed using a gas chromatograph mass spectrometer (GCMS).
Chromatographic conditions are as follows: HP-5 quartz capillary
column (30 mm  0.25 mm  0.25 mm) was warmed from 50 C to
160 C at 3 C/min, maintained for 2 min, warmed to 280 C at
10 C/min, and then maintained until the component analysis was
ﬁnished. Feed volume was 0.2 mL. High purity He (0.99999) wasr B.V. All rights reserved.
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For mass spectrum the ion source temperature was 220 C, injec-
tion port temperature was 240 C, and electron energy was 70 eV.
And diluents at 50, 80 and 100mmol/L were prepared using tween-
80 (1%) and serum-free RPMI-1640 medium as described previ-
ously (9).
Methyl thiazolyl tetrazolium (MTT), propidium iodide (PI) and
RNase A were purchased from Amresco (Solon, OH); RPMI-1640
culture medium and new-born calf serum from Gibco (GrandIs-
land, NY); ﬂuorescent quantitative reverse transcription-PCR kit
from Takara (Tokyo, Japan); mouse anti-human cell cycle depend
on kinase 1 (CDK1), CyclinB1 and Cdc25C monoclonal antibodies
were purchased from Millipore (Billerica, MA); actin and rabbit
anti-human CDK1 p34 (Tyr15) phosphorylated polyclonal anti-
bodies were obtained from Santa Cruz (Santa Cruz Biotechnology
Inc., Santa Cruz, CA).
2.2. Cell culture
Liver cancer cell BEL-7402 was obtained from China Center for
Type Culture Collection of Wuhan University and was cultured in
RPMI-1640 complete culture medium containing 10% new-born
calf serum, 100 U/mL penicillin and 100 mg/mL streptomycin and
incubated at 37 C in a humidiﬁed atmosphere containing 5% CO2.
After several passages, cells in the logarithmic phase were
collected.
2.3. MTT assay
Liver cancer BEL-7402 cells were maintained in RPMI-1640
medium, which consists of, 10% fetal bovine serum, 100 U/ml
penicillin and 100 mg/ml streptomycin, at 37 C in a humidiﬁed
atmosphere containing 5% CO2. Cell growth in the presence or
absence of a-pinene was determined using MTT assay (10). Brieﬂy,
rapidly growing cells were harvested, counted and inoculated at
the concentration of 5107/mL with 100 mL in each well of 96-well
plate. The cells were then incubated for indicated times in the
absence or in the presence of different a-pinene. Then 20 mL of
5 mg/ml MTT was added and incubated in dark at 37 C for 4 h.
After removal of the MTT, cells were treated with 100 uL 5% SDS.
The absorbance was determined at 570 nm using the Automated
Microplate Reader (Sunrise, Tecan, Switzerland).
2.4. Cell cycle analysis
PI staining was used to analyze the cycling characteristics of cell
populations. Brieﬂy, logarithmically growing BEL-7402 cells were
treated with 8.4 mM a-pinene for 24, 48 and 72 h. Cells were then
harvested and ﬁxed in 70% ethanol at 4 Covernight. Cells were
subsequently resuspended in 0.5 mL 50 mg/mL PI staining solution,
kept in the dark at room temperature for 30 min, and analyzed by
the Coulter Epica XL Flow Cytometer (Beckman, USA). The cell cycle
distribution was analyzed with the Muticycle for Windows 32 Bit
USB software.
2.5. Tumor xenograft model and a-pinene treatment
30 nude mice aged 5e6 weeks were purchased from Guang-
dong Provincial Experimental Animal Center and were divided
into three groups (a-pinene-treated group, isotonic sodium
chloride group as model control and 5-FU-treated group as pos-
itive control) randomly. 2  106 BEL-7402 cells in logarithmic
phase were subcutaneously inoculated in the posterior right hind
limb of each nude mouse. When tumors reached a diameter of
3e4 mm. 200 mL of a-pinene (2.67 mL/kg) as a-pinene-treatedgroup, normal isotonic sodium chloride of 0.2 mL/d as model
control, and 5-FU of 0.67 mL/kg as positive control were injected
subcutaneously for 14 ten days every two days. The longest
diameter (a) and shortest diameter (b) of the tumor were
measured using a caliper. Tumor volume was considered equal to
(a  b2)/2. Mice with tumor volume larger than 1000 mm3 will be
sacriﬁced. Nude mice were sacriﬁced two days after the last
administration, and tumors were collected and weighed. Calcu-
lated the tumor inhibitory rate according to the following equa-
tion. Inhibitory rate was used to evaluate a-pinene's effect against
tumors. Inhibitory rate no less than 30% was regarded as valid,
and less than 30% as invalid (11).
Tumor inhibitory rate ¼ (Average tumor weight of model
contrast group- Average tumor weight of administered group)/
Average tumor weight of model contrast group  100%
2.6. Histology and immunohistology
Tumor tissues collected from nude mouse xenograft models
were ﬁxed in 4% paraformaldehyde, embedded in parafﬁn, and cut
into 4 mm sections. After deparafﬁnization and rehydration, sec-
tions were processed for H&E staining.
Immunostaining was performed on deparafﬁnized tissue sec-
tions. Specimens were treated with 3% H2O2 at room temperature
for 30 min, processed for antigen retrieval by microwave, blocked
with normal goat serum for 15 min, and incubated with primary
antibody (1:100) against Chk1, Chk2, CyclinB, CDC25 or CDK1 at
4 C overnight. For immunochemical staining, sections were incu-
bated at 37 C for 15 min with biotinylated secondary antibody
(1:100), followed by incubation in horseradish enzyme-labeled
streptomycin avidin at 37 C for 15 min. Sections were then
developed in 3, 30-diaminobenzidine for 30 s. Subsequently, sec-
tions were counterstained with hematoxylin and mounted in
neutral resin. For immunoﬂuorescence staining, rat anti- or rabbit
anti-monoclonal ﬂuorescent antibodies (1:150) was used as sec-
ondary antibodies and samples were incubated with secondary
antibody at 37 C for 60 min. After washing with Tris-buffered sa-
line Tween-20, slides were mounted with ﬂuorescent mounting
medium.
All slices were observed under light microscope and were taken
photographs.
2.7. Transmission electron microscopy
2 mL (3  106) of the control and a-pinene-treated cells were
centrifuged at 2000 r/min for 10 min. Cell pellets were precooled at
4 C, followed by preﬁxation in 2% glutaraldehyde and postﬁxation
in 1% osmic acid. After dehydration, samples were then embedded
in epoxy resin and sliced into ultrathin sections. Sections were
stained using lead acetate-uraniummethod. Photoscopy were done
using a transmission electron microscope.
2.8. Western blot
Tumor samples were collected (eight days after a-pinene
treatment), washed and homogenized. Equal amounts of protein
were separated in 10% SDS-PAGE and transferred onto poly-
vinylidenediﬂuoride membranes (Millipore, Billerica, MA). Mem-
branes were probed with primary antibodies (Chk1, Chk2, CyclinB,
CDC25 and CDK1) and then were detected using horseradish
peroxidase-conjugated goat anti-rabbit IgG (Millpore). Bands were
visualized by enhanced chemiluminescence (ECL Plus, Amersham)
and quantiﬁed by AlphaEase FCsoftware (Alpha Innotech, San
Leandro, CA).
Figure 1. Cell growth analysis using MTT assay. BEL-7402 cells were treated with a-
pinene with indicated concentration, cells were collected and subject to MTT assay at
indicative time point.
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The datawere analyzed using SPSS 10.0 software, and expressed
as mean ± SD from three separate experiments. The differences
between groups were analyzed using Student's t test (two-sided).
Differences were considered to be statistically signiﬁcant at
P < 0.05.
3. Results
3.1. a-pinene inhibits BEL-7402 cell growth
We initiated our test by checking the effect of a-pinene on BEL-
7402 cell growth utilizing MTT assay. BEL-7402 cells were treated
with a-pinene at the concentrations of 8 mg/L, 2 mg/L, 0.5 mg/L and
0.125 mg/L, respectively. MTT assay was then applied at 24 h, 48 h
and 72 h. As shown in Fig. 1, a-pinene showed inhibitory effect on
BEL-7402 cell growth in a dose- and time-dependent manner. The
cell growth inhibitory rate was as high as 79.3% (P < 0.05) when a-
pinene was applied at the concentration of 8 mg/L for 72 h. The
result suggests that a-pinene can effectively inhibits cell growth.
3.2. a-pinene blocks BEL-7402 cells in G2/M phase
To better understand the mechanism underlying cell growth
suppression by a-pinene, the impact of a-pinene on cell cycleFigure 2. a-pinene inhibits tumor cell growth in vitro and in vivo. (A) Bel-7402 cells treated
distribution analysis. Left panel: control group; right panel: a-pinene-treated group. (B) M
growth was monitored and growth curves of tumors are shown.progression was investigated. BEL-7402 cells were treated with
either a-pinene or PBS, and cell cycle distribution analysis was then
performed 24 h, 48 h and 72 h. As shown in Fig. 2A, G2/M popu-
lation of a-pinene-treated BEL-7402 cells was increased during the
period of 24e72 h post-treatment, from 7.7% at 0 time point to
23.1% at 72 h post-treatment, while no obvious alteration was
observed in the control cells. This result revealed that a-pinene
treatment caused marked accumulation of a G2/M population in
BEL-7402 cells.
3.3. a-pinene suppresses tumor growth in a xenograft model
Given that a-pinene blocks G2/M progression and cell growth,
we further tested its tumor suppressing ability by using a BEL-7402
xenograft model. Mice bearing tumor xenografts were treated with
a-pinene or 5-FU (positive control) when tumors reached a diam-
eter of 3e4 mm. The growth of tumor was then monitored every
two days. As compared to control group where mice were treated
with isotonic sodium chloride, tumor volume was signiﬁcantly
inhibited in both a-pinene and 5-FU treated groups (Fig. 2B). No
mice died in the experimental and positive control groups. Two
weeks after treatment, mice were sacriﬁced and tumors were
measured and weighted. The average tumor size in a-pinene-
treated group was signiﬁcantly smaller than that in the control
group (229.21 ± 64.77 mm3 vs. 683.07 ± 42.36 mm3, P < 0.01), and
comparable to 5-FU treated group (323.883 ± 27.8 mm3). Consis-
tent with this result, the average tumor weight in a-pinene-treated
group was signiﬁcantly lighter than the control (0.253 ± 0.093 g vs.
0.353 ± 0.032 g, P < 0.05), and similar to that in 5-FU treated group
(0.353 ± 0.032 g). (Table 1). In consistent to this data, histology
examination of xenografts from treated mice showed a lot more
dead cells and slow-growing cells in a-pinene treated and 5-FU
treated tumors as compared to the control (Fig. 3). Moreover,
apoptosis cell death after a-pinene treatment was also evident from
the scanning electronmicroscopy result (Fig. 4). Our results suggest
that a-pinene signiﬁcantly suppresses growth of tumor cells in the
tumor-bearing mice.
3.4. Molecular alteration induced by a-pinene treatment
To further understand the mechanism, we explored the mo-
lecular changes that associated with a-pinene in the BEL-7402
xenograft model. As a-pinene also blocked G2/M transition in our
cell model, a list of G2/M checkpoint proteins were herein analyzed
by immunohistochemistry. As shown in Fig. 3, the expression of
Chk1 and Chk2 were increased in a-pinene-treated group and 5-with or without a-pinene were collected 48 h after treatment and subject to cell cycle
ice with BEL-7402 xenograft tumors were treated with or without a-pinene. Tumor
Table 1
Inhibitory rate of a-pinene on tumor growth in the nude mice (x±s, n ¼ 8).
Group Tumor
volume (mm3)
Tumor
weight (g)
Inhibitory
rate (%)
Blank control 683.07 ± 42.36 0.82 ± 0.147
Positive control 323.883 ± 27.8** 0.353 ± 0.032* 56.911
Experimental 229.21 ± 64.77** 0.253 ± 0.093* 69.106
**P < 0.01; * < 0.05, vs. blank control group.
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expression of Cyclin B, CDC25 and CDK1 decreased.
To conﬁrm that these molecular changes were induced by
a-pinene, immunoﬂuorescence staining (Fig. 5) and western blotFigure 3. Representive photografts of hematoxylineosin staining and immunohistochemi(Fig. 6) were therefore performed. Again, we observed upregulated
Chk1 and Chk2 protein level and downregulated Cyclin B, CDC25
and CDK1 protein level in a-pinene treated cells, as well as 5-FU
treated cells which were served as the positive control.
Collectively, our data indicate molecular changes in the G2/M
check point pathway induced by a-pinene, which is associatedwith
a-pinene induced cell growth inhibition.
4. Discussion
In China, liver cancer is the second most common cause of
cancer morbidity and mortality. About 35, 000 individuals are
diagnosed as liver cancer every year and about 32, 000stry in BEL-7402 xenografts collected (eight days) after a-pinene treatment. ( 200).
Figure 4. Effect of a-pinene on the protein levels of CDC25, CDK1, CyclinB1, Chk1 and Chk2 in BEL-7402 xenograft tumors collected (eight days/h) after a-pinene treatment.
Immunoﬂuorescence of CDC25C, CDK1, CyclinB1, Chk1 and Chk2 in xenografts. (A) Representative microscopy photografts from immunoﬂuorescence results ( 200). (B): Quantiﬁed
immunoﬂuorescence signals from (A).
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liver cancer are limited to resection or liver transplantation.
However, even though some patients are eligible for operation,
the ﬁve-year survival rate is only 7% (12). Since Rygarrd ﬁrstly
transplanted human tumor cells into nude mice in 1969, nude
mouse xenograft tumor models with human tumor cells are
widely used. Thereafter, nude mouse xenograft tumor models
have became an extensively used method in cancer investigation.
Uncontrolled cell growth is one of the characteristics of human
cancers. While cell growth is normally restrained by the control
of cell cycle, cell division cycle is under the regulation of the Cdk
family of serin/threonine kinase and cyclins. G2/M transition isFigure 5. Representive photografts of BEL-7402 xenografts from each group under an ele
control); C: a-pinene treated group.regulated by CyclinB1/CDC2 complex in mammalian cells (13,
14), and the activity of this complex is regulated by many fac-
tors. For example, dual speciﬁcity phosphatase CDC25C activates
CDC2 via upholding phosphorylation on the Thr14 and Tyr15 of
CDC2 (15). p53 also plays a role on the guardian of G2/M check
point; p53 activates the transcription of p21 and 14-3-3s (16, 17).
While p21 directly suppresses activities of CDC2 (18), and in-
terferes with PCNA and CDC25 (19), 14-3-3s binds to CyclinB1
and excludes it from the nucleus (20). Moreover, the dissociation
of CDK1-CyclinB1 complexes is also mediated by p53 through
inducing Gadd45 (Growth arrest and DNA damage inducible
gene) (21, 22).ctron microscope ( 6000). A: Blank control group; B: 5-FU treated group (positive
Figure 6. Effect of a-pinene on the protein levels of CDC25, CDK1, CyclinB1, Chk1 and Chk2 in BEL-7402 xenograft tumors collected (eight days) after a-pinene treatment. (A)
Western blot results showing the expression levels of CDC25, CDK1, CyclinB1, Chk1 and Chk2. b-actin was used as the internal control. (B) Summary of a-pinene effects on
expression of CDC25, CDK1, CyclinB1, Chk1 and Chk2. Data were expressed as mean ± SEM of three independent experiments. *P < 0.05 versus control.
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mor suppressing ability of a-pinene by using a BEL-7402 xenograft
model because 5-FU has been widely used for cancer patients. The
results showed that 5-FU had inhibition on BEL-7402 cell.
Our study found that cell cycle transition from G2 phase to M
phase was inhibited by a-pinene in BEL-7402 cells. It has also been
reported that inhibition of BEL-7402 cell differentiation by a-
pinene involves G2/M arrest (23), and this result was conﬁrmed by
our experiment. We further found that the Chk2-CDC25 pathway is
involved. The results of immunostaining and western blot revealed
a reduction of Cyclin B protein level after a-pinene treatment,
which is associated with G2/M cell cycle arrest. Chk1 and Chk2, the
core of DNA injury check, inhibits CDC2 activity and block mitosis
by suppressing CDC25 phosphatase activity through phosphoryla-
tion. Interestingly, we found Chk1 and Chk2 levels were upregu-
lated after a-pinene treatment, while CDC25 and CDNK1 levels
were downregulated. Therefore, we presumed that a-pinene
induced cell-cycle arrest is regulated by Chk2 and CDC25C. How-
ever, whether other signal pathways are also involved in the pro-
cess of cell growth inhibition needs further investigation. Our
studies further provide theoretical evidence for the treatment of
liver cancer. Although late-stage tumor growth cannot be
controlled using a-pinene alone, its combination with other
chemotherapeutic drugs might reduce drug resistance and prolong
survival time of cancer patients.
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